Literature DB >> 7910421

Dopaminergic neurotoxicity of cyanide: neurochemical, histological, and behavioral characterization.

A G Kanthasamy1, J L Borowitz, G Pavlakovic, G E Isom.   

Abstract

Previous reports have shown that dopamine (DA) is depleted in the brains of animals treated with cyanide. To develop a model for studying the mechanisms of cyanide-induced changes in dopaminergic systems, mice were treated with cyanide (KCN, 6 mg/kg, sc) twice a day for 7 days and 16 hr after the last dose neurochemical, histological, or behavioral parameters were evaluated. DA levels in KCN-treated animals decreased in the striatum (41%), hippocampus (30%), and cerebral cortex (13%) as compared to saline-treated controls. In striatal and hippocampal tissues, but not in cerebral cortex, malondialdehyde levels increased 43 and 57%, respectively, as compared to controls, indicating that peroxidation of lipids occurred in these brain areas. Over 30% of the treated mice exhibited decreased locomotor activity and akinesia, which were suppressed by l-DOPA (100 mg/kg, ip). Tyrosine hydroxylase (TH) immunohistochemical examination of brains from cyanide-treated animals showed a reduced number of TH-positive cells in substantia nigra, indicating a loss of dopaminergic neurons. In contrast, acute cyanide (KCN, 6 mg/kg, sc) did not produce significant neurochemical or behavioral changes. Under these treatment conditions, cyanide produces a central dopaminergic toxicity which is characterized by decreased DA levels in select brain areas, impaired locomotor activity, and neuronal damage.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7910421     DOI: 10.1006/taap.1994.1102

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  7 in total

1.  Neurochemical and behavioural correlates in cassava-induced neurotoxicity in rats.

Authors:  D C Mathangi; A Namasivayam
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

2.  A novel paradigm for assessing efficacies of potential antidotes against neurotoxins in mice.

Authors:  Daune L Crankshaw; David J W Goon; Jacquie E Briggs; David DeLong; Michael Kuskowski; Steven E Patterson; Herbert T Nagasawa
Journal:  Toxicol Lett       Date:  2007-10-10       Impact factor: 4.372

Review 3.  Chemical exposure and hearing loss.

Authors:  Pierre Campo; Thais C Morata; OiSaeng Hong
Journal:  Dis Mon       Date:  2013-04       Impact factor: 3.800

Review 4.  Novel cell death signaling pathways in neurotoxicity models of dopaminergic degeneration: relevance to oxidative stress and neuroinflammation in Parkinson's disease.

Authors:  Anumantha Kanthasamy; Huajun Jin; Suneet Mehrotra; Rajakishore Mishra; Arthi Kanthasamy; Ajay Rana
Journal:  Neurotoxicology       Date:  2009-12-11       Impact factor: 4.294

5.  Aberrant regulation of choline metabolism by mitochondrial electron transport system inhibition in neuroblastoma cells.

Authors:  Ahmet T Baykal; Mohit R Jain; Hong Li
Journal:  Metabolomics       Date:  2008-12-01       Impact factor: 4.290

6.  Decay accelerating factor (CD55) protects neuronal cells from chemical hypoxia-induced injury.

Authors:  Ying Wang; Yansong Li; Shawn L Dalle Lucca; Milomir Simovic; George C Tsokos; Jurandir J Dalle Lucca
Journal:  J Neuroinflammation       Date:  2010-04-09       Impact factor: 8.322

7.  Behavioral toxicity of sodium cyanide following oral ingestion in rats: Dose-dependent onset, severity, survival, and recovery.

Authors:  Nathaniel C Rice; Noah A Rauscher; Jeffrey L Langston; Todd M Myers
Journal:  Food Chem Toxicol       Date:  2018-02-16       Impact factor: 6.023

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.